| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |